首页> 美国卫生研究院文献>Cancer Biology Therapy >Next-generation sequencing of prostate cancer: genomic and pathway alterations potential actionability patterns and relative rate of use of clinical-grade testing

【2h】

Next-generation sequencing of prostate cancer: genomic and pathway alterations potential actionability patterns and relative rate of use of clinical-grade testing

机译：下一代前列腺癌测序：基因组和途径改变潜在的可操作性模式以及临床级检测的相对使用率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Cancer Biology Therapy
作者
Sadakatsu Ikeda; Sheryl K. Elkin; Brett N. Tomson; Jennifer L. Carter; Razelle Kurzrock;
展开▼
作者单位

展开▼
年(卷),期 2019(20),2
年度 2019
页码 219–226
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
prostate cancer genomic profiling next-generation sequencing molecular targeted therapy mutation;

机译：前列腺癌;基因组分析;下一代测序;分子靶向治疗;突变;

相似文献

外文文献
中文文献
专利

1. Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing [J] . Ikeda Sadakatsu, Elkin Sheryl K., Tomson Brett N., Cancer biology & therapy . 2019,第1a3期

机译：前列腺癌的下一代测序：基因组和途径改变，潜在的可致合法性模式，以及临床级测试的相对使用速率
2. Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing [J] . Ikeda Sadakatsu, Elkin Sheryl K., Tomson Brett N., Nature reviews neuroscience . 2019,第2期

机译：前列腺癌的下一代测序：基因组和途径改变，潜在的可持续性模式，以及临床级测试的相对使用率
3. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches [J] . Drilon Alexander, Wang Lu, Arcila Maria E., Clinical cancer research: an official journal of the American Association for Cancer Research . 2015,第16期

机译：广泛的，基于混合捕获的下一代测序技术可确定肺腺癌中可操作的基因组改变，否则通过其他基因组测试方法对此类改变不利
4. Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer [C] . Simeen Malik, Sophie Ran Wang, Iam Beehuat Tan, International Molecular Medicine Tri-Conference. . 2016

机译：用于检测胃肠道癌患者可操作突变的下一代测序测定的技术验证
5. Sequencing-Based Computational Methods for Identifying Impactful Genomic Alterations in Cancers. [D] . Joseph, Isaac Charles. 2016

机译：基于序列的计算方法，用于识别癌症中有影响的基因组变化。
6. Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms [O] . Sun Hee Rosenthal, Anna Gerasimova, Charles Ma, 2021

机译：48基因下一代测序面板的分析验证和性能特征用于检测骨髓肿瘤中的潜在可操作的基因组改变
7. Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing [O] . Sadakatsu Ikeda, Sheryl K. Elkin, Brett N. Tomson, 2018

机译：前列腺癌的下一代测序：基因组和途径改变，潜在的可致合法性模式，以及临床级测试的相对使用速率

Next-generation sequencing of prostate cancer: genomic and pathway alterations potential actionability patterns and relative rate of use of clinical-grade testing

著录项

相似文献

相关主题

期刊订阅